N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide
C20H27N5O6S — CID 135798117
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide
N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide (PubChem CID 135798117) has the molecular formula C20H27N5O6S and a molecular weight of 465.53 g/mol. Its IUPAC name is N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide.
Molecular Properties
| Compound Name | N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide |
|---|---|
| PubChem CID | 135798117 |
| Molecular Formula | C20H27N5O6S |
| Molecular Weight | 465.53 g/mol |
| Exact Mass | 465.17 |
| IUPAC Name | N,N-bis(2-hydroxyethyl)-4-methoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)benzenesulfonamide |
| SMILES | CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N(CCO)CCO)ccc3OC)nc12 |
| InChI | InChI=1S/C20H27N5O6S/c1-4-5-15-17-18(24(2)23-15)20(28)22-19(21-17)14-12-13(6-7-16(14)31-3)32(29,30)25(8-10-26)9-11-27/h6-7,12,26-27H,4-5,8-11H2,1-3H3,(H,21,22,28) |
| InChIKey | XKIMIBOJSLMOPO-UHFFFAOYSA-N |
| XLogP | 0.26 |
| TPSA | 150.64 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.53 |
| LogP ≤ 5 | 0.26 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135798117 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.